On March 5, the AANS and the CNS led a letter signed by over 40 other leading medical organizations to the National Institutes of Health (NIH) expressing concerns over the agency’s new policy imposing a 15 percent cap on indirect cost rates for all NIH grants. The letter highlights the potential impact of this change on the long-term sustainability of the U.S. biomedical research enterprise. It underscores the importance of working together to find a balanced solution.
The same day, the AANS and the CNS issued a press release announcing the letter and urging collaboration on the NIH indirect cost policy. Following the press release, Becker’s Spine Review published an article titled “Spine groups urge collaboration on NIH grant policy,” and the San Diego Union-Tribune published an article, UCSD neurosurgeon rallies broad national support in fight to save research funding.
The letter was also submitted to the Senate Appropriations Committee ahead of their April 30 hearing, Biomedical Research: Keeping America’s Edge in Innovation.
